Skip to content

Author

Wenjing Xiong

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

The value of LAR in predicting neoadjuvant therapy response and prognosis in HER2-positive breast cancer.

BACKGROUND In the personalized treatment of HER2-positive breast cancer, identifying biomarkers predictive of neoadjuvant therapy (NAT) response and long-term prognosis is crucial. This study investigates the association between the lactate dehydrogenase-to-albumin ratio (LAR) and both NAT efficacy and survival outcome...

Xiaojing Li, Xin Xin, Wenjing Xiong et al. · 0 citations
Review Open access Jul 2026

ADAM12 in a stromal-checkpoint framework: integrating tumor microenvironment remodeling and therapy resistance in solid tumors

An integrative stromal-checkpoint framework is used to describe stromal programs that couple extracellular matrix remodeling, metabolic stress, vascular dysfunction, and immune exclusion into treatment-resistant tumor ecologies and discusses how ADAM12-informed biomarkers, spatial barrier profiling, and stromal-priming...

Shao-Chun Liu, Jian Xu, Han Zhang et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.